Association of maternal pancreatic function and foetal growth in rats treated with DFU, a selective cyclooxygenase-2 inhibitor

Folia Morphologica

Volumn 66, Issue 3, 2007, Pages 172-180

  Burdan, F ^a   Szumilo J ^a   Dudka, J ^a   Szumilo M ^a   Korobowicz, A ^a   Chatterjee, S ^a   Klepacz, R ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Coxibs; Cyclooxygenase; Diabetes; Foetus; Glucose; Macrosomia; NSAID; Pregnancy

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; AMYLASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GLUCOSE; ISOENZYME; NONSTEROID ANTIINFLAMMATORY AGENT;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ENZYME ACTIVITY; FETUS; FETUS (ANATOMY); FETUS GROWTH; GESTATION PERIOD; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MAMMAL; MATERNAL SERUM; MOTHER; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET; PREGNANCY; PROTEIN EXPRESSION; RAT; WISTAR RAT;

AMYLASES; ANIMALS; BODY WEIGHT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; FETAL DEVELOPMENT; FURANS; GLUCOSE; ISOENZYMES; MALE; PANCREAS; PREGNANCY; RATS; RATS, WISTAR;

MAMMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 34548771881     PISSN: 00155659     EISSN: 16443284     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alhan E, Kalyoncu NI, Ercin C, Kural BV (2004) Effects of the celecoxib on the acute necrotizing pancreatitis in rats. Inflammation, 28: 303-309.
2. Alm P, Ekstrom P, Henningsson R, Lundquist I (1999) Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: an immunocytochemical and confocal microscopical study. Diabetologia, 42: 978-986.
3. Burdan F, Chalas A, Szumilo J (2006) Cyclooxygenase and prostanoids - biological implications. Post Hig Med Dosw, 60: 129-141.
4. Burdan F, Radzikowska E, Wyskiel M, Urbanowicz Z (1999) Drug-induced pancreatic injury during pregnancy. In: Mackiewicz Z (ed) Selected surgical problems. Vol. 4. Fundacja Polski Przeglad Chirurgiczny, Warszawa, pp. 168-171.
5. Burdan F, Szumilo J, Dudka J, Korobowicz A, Fronczek A, Klepacz R, Wojtowicz Z (2007) Pancreatic morphology in pregnant rats exposed to DuP-697 - the irreversible, highly selective cyclooxygenase-2 inhibitor. Ann Univ Mariae Curie Sklodowska Med, 62 (in press).
6. Burdan F, Szumilo J, Dudka J, Radzikowska E, Klepacz R (2006) Constitutive and inducible cyclooxygenase isoforms expressed in rat pancreas. Ann Univ Mariae Curie Sklodowska Med, 61: 572-575.
7. Burdan F, Szumilo J, Klepacz R, Dudka J, Korobowicz A, Tokarska E, Cendrowska-Pinkosz M, Madej B, Klepacz L (2004) Gastrointestinal and hepatic toxicity of selective and non-selective cyclooxygenase-2 inhibitors in pregnant and non-pregnant rats. Pharmacol Res, 50: 533-543.
8. Burdan F (2005) Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats - DFU and piroxicam study. Toxicology, 211: 12-25.
9. Carrillo-Jimenez R, Nurnberger M (2000) Celecoxib-induced acute pancreatitis and hepatitis: a case report. Arch Intern Med, 160: 553-554.
10. de Almeida JL, Jukemura J, Coelho AM, Patzina RA, Machado MC, da Cunha JE (2006) Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis. Clinics, 61: 301-306.
11. Ethridge RT, Chung DH, Slogoff M, Ehlers RA, Hellmich MR, Rajaraman S, Saito H, Uchida T, Evers BM (2002) Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology, 123: 1311-1322.
12. Fitzpatrick FA (2004) Cyclooxygenase enzymes: regulation and function. Curr Pharm Des, 10: 577-588.
13. Fuglsang J, Lauszus FF, Fisker S, Flyvbjerg A, Ovesen P (2005) Growth hormone binding protein and maternal body mass index in relation to placental growth hormone and insulin requirements during pregnancy in type 1 diabetic women. Growth Horm IGF Res, 15: 223-230.
14. Gabbe SG, Quilligan EJ (1977) Fetal carbohydrate metabolism: its clinical importance. Am J Obstet Gynecol, 127: 92-103.
15. Han X, Chen S, Sun Y, Nadler JL, Bleich D (2002) Induction of cyclooxygenase-2 gene in pancreatic beta-cells by 12-lipoxygenase pathway product 12-hydroxyeicosatetraenoic acid. Mol Endocrinol, 16: 2145-2154.
16. Hedderson MM, Weiss NS, Sacks DA, Pettitt DJ, Selby JV, Quesenberry CP, Ferrara A (2006) Pregnancy weight gain and risk of neonatal complications: macrosomia, hypoglycemia, and hyperbilirubinemia. Obstet Gynecol, 108: 1153-161.
17. Hughes JH, Easom RA, Wolf BA, Turk J, McDaniel ML (1989) Interleukin 1-induced prostaglandin E2 accumulation by isolated pancreatic islets. Diabetes, 38: 1251-1257.
18. Ishizuka T, Klepcyk P, Liu S, Panko L, Liu S, Gibbs EM, Friedman JE (1999) Effects of overexpression of human GLUT4 gene on maternal diabetes and fetal growth in spontaneous gestational diabetic C57BLKS/J Lepr(db/+) mice. Diabetes, 48: 1061-1069.
19. Jansson T, Cetin I, Powell TL, Desoye G, Radaelli T, Ericsson A, Sibley CP (2006) Placental transport and metabolism in fetal overgrowth - a workshop report. Placenta, 27 (Suppl. A): S109-S113.
20. Kautzky-Willer A, Bancher-Todesca D (2003) Gestational diabetes. Wien Med Wochenschr, 153: 478-484.
21. Koliopanos A, Friess H, Kleeff J, Roggo A, Zimmermann A, Buchler MW (2001) Cyclooxygenase 2 expression in chronic pancreatitis: correlation with stage of the disease and diabetes mellitus. Digestion, 64: 240-247.
22. Lucas MJ (2001) Diabetes complicating pregnancy. Obstet Gynecol Clin North Am, 28: 513-536.
23. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY (2002) Glucose-induced beta cell production of IL-1 beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest, 110: 851-860.
24. Miedzybrodzki R (2004) Trends in nonsteroidal anti-inflammatory drug development and application. Post Hig Med Dosw, 58: 438-448.
25. Neufeld ND, Corbo L (1982) Increased fetal insulin receptors and changes in membrane fluidity and lipid composition. Am J Physiol, 243: E246-E250.
26. Shanmugam N, Todorov IT, Nair I, Omori K, Reddy MA, Natarajan R (2006) Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice. Diabetologia, 49: 100-107.
27. Sjoholm A (1991) Inhibition of fetal rat pancreatic beta-cell replication by interleukin-1 beta in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation. FEBS Lett, 289: 249-252.
28. Streck RD, Kumpf SW, Ozolins TR, Stedman DB (2003) Rat embryos express transcripts for cyclooxygenase-1 and carbonic anhydrase-4, but not for cyclooxygenase-2 during organogenesis. Birth Defects Res B Dev Reprod Toxicol, 68: 57-69.
29. Tabatabaie T, Waldon AM, Jacob JM, Floyd RA, Kotake Y (2000) COX-2 inhibition prevents insulin-dependent diabetes in low-dose streptozotocin-treated mice. Biochem Biophys Res Commun, 273: 699-704.
30. Tran PO, Gleason CE, Poitout V, Robertson RP (1999) Prostaglandin E(2) mediates inhibition of insulin secretion by interleukin-1 beta. J Biol Chem, 274: 31245-3128.
31. Warner TD, Mitchell JA (2004) Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J, 18: 790-804.
32. Zabel-Langhennig A, Holler B, Engeland K, Mossner J (1999) Cyclooxygenase-2 transcription is stimulated and amylase secretion is inhibited in pancreatic acinar cells after induction of acute pancreatitis. Biochem Biophys Res Commun, 265: 545-549.